171 related articles for article (PubMed ID: 35250301)
1. CDK3, CDK5 and CDK8 Proteins as Prognostic and Potential Biomarkers in Colorectal Cancer Patients.
Wang D; Zhou Y; Hua L; Li J; Zhu N; Liu Y
Int J Gen Med; 2022; 15():2233-2245. PubMed ID: 35250301
[TBL] [Abstract][Full Text] [Related]
2. Changes in cyclin dependent kinase expression and activity accompanying lens fiber cell differentiation.
Gao CY; Rampalli AM; Cai HC; He HY; Zelenka PS
Exp Eye Res; 1999 Dec; 69(6):695-703. PubMed ID: 10620399
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of Role of Cyclin-Dependent Kinases Family Members in Colorectal Cancer.
Guan L; Tang Y; Li G; Qin Z; Li S
Front Oncol; 2022; 12():921710. PubMed ID: 35814446
[TBL] [Abstract][Full Text] [Related]
4. Verification of cell cycle-associated cyclin-dependent kinases facilitated prostate cancer progression by integrated bioinformatic analysis and experimental validation.
Huang Y; Lu S; Chen Y; Qing Y; Wu R; Ma T; Zhang Z; Wang Y; Li K
Heliyon; 2022 Aug; 8(8):e10081. PubMed ID: 36033322
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin-dependent kinases and their clinical significance with immune infiltrates could predict prognosis in colorectal cancer.
Fadaka AO; Samantha Sibuyi NR; Bakare OO; Klein A; Madiehe AM; Meyer M
Biotechnol Rep (Amst); 2021 Mar; 29():e00602. PubMed ID: 33732631
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy.
Robb CM; Kour S; Contreras JI; Agarwal E; Barger CJ; Rana S; Sonawane Y; Neilsen BK; Taylor M; Kizhake S; Thakare RN; Chowdhury S; Wang J; Black JD; Hollingsworth MA; Brattain MG; Natarajan A
Oncotarget; 2018 Jan; 9(4):5216-5232. PubMed ID: 29435174
[TBL] [Abstract][Full Text] [Related]
7. Discovery of CDK signature and CDK5 as potential biomarkers for predicting prognosis and immunotherapeutic response in gastric cancer peritoneal metastases.
Sun Y; Chen Y; Cai Y; Wang X; Chen Q; Fang S; Lian M; Lv C; Weng J; Huang R; Zhuang W; Xue F; Cai L; Lin Y; Wang Q
Am J Cancer Res; 2023; 13(9):4087-4100. PubMed ID: 37818084
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the development of selective small molecule inhibitors for cyclin-dependent kinases.
Hirai H; Kawanishi N; Iwasawa Y
Curr Top Med Chem; 2005; 5(2):167-79. PubMed ID: 15853645
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and characterisation of p15(CDK-BP), a novel CDK-binding protein.
Vogel L; Baratte B; Détivaud L; Azzi L; Leopold P; Meijer L
Biochim Biophys Acta; 2002 Apr; 1589(2):219-31. PubMed ID: 12007796
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinases.
Malumbres M
Genome Biol; 2014; 15(6):122. PubMed ID: 25180339
[TBL] [Abstract][Full Text] [Related]
11. Deregulated expression of CDK2- or CDK3-associated kinase activities enhances c-Myc-induced apoptosis.
Braun K; Hölzl G; Pusch O; Hengstschläger M
DNA Cell Biol; 1998 Sep; 17(9):789-98. PubMed ID: 9778038
[TBL] [Abstract][Full Text] [Related]
12. Structure of the mediator subunit cyclin C and its implications for CDK8 function.
Hoeppner S; Baumli S; Cramer P
J Mol Biol; 2005 Jul; 350(5):833-42. PubMed ID: 15979093
[TBL] [Abstract][Full Text] [Related]
13. Structural Bioinformatics Approach of Cyclin-Dependent Kinases 1 and 3 Complexed with Inhibitors.
Saraiva LA; Veloso MP; Camps I; da Silveira NJ
Mol Inform; 2011 Mar; 30(2-3):219-31. PubMed ID: 27466775
[TBL] [Abstract][Full Text] [Related]
14. Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy.
Chou J; Quigley DA; Robinson TM; Feng FY; Ashworth A
Cancer Discov; 2020 Mar; 10(3):351-370. PubMed ID: 32071145
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation.
Sharma P; Sharma M; Amin ND; Albers RW; Pant HC
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11156-60. PubMed ID: 10500146
[TBL] [Abstract][Full Text] [Related]
16. Identification of the Effects of Chondroitin Sulfate on Inhibiting CDKs in Colorectal Cancer Based on Bioinformatic Analysis and Experimental Validation.
Zhou Y; Li X; Morita Y; Hachimura S; Miyakawa T; Takahashi S; Tanokura M
Front Oncol; 2021; 11():705939. PubMed ID: 34595111
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclin-dependent kinases by p21.
Harper JW; Elledge SJ; Keyomarsi K; Dynlacht B; Tsai LH; Zhang P; Dobrowolski S; Bai C; Connell-Crowley L; Swindell E
Mol Biol Cell; 1995 Apr; 6(4):387-400. PubMed ID: 7626805
[TBL] [Abstract][Full Text] [Related]
18. Cdk1 is sufficient to drive the mammalian cell cycle.
Santamaría D; Barrière C; Cerqueira A; Hunt S; Tardy C; Newton K; Cáceres JF; Dubus P; Malumbres M; Barbacid M
Nature; 2007 Aug; 448(7155):811-5. PubMed ID: 17700700
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic value of transcription-associated cyclin-dependent kinases in human breast cancer.
Li N; Zheng S; Xue Z; Xiong Z; Zou Y; Tang Y; Wei WD; Yang L
Aging (Albany NY); 2021 Mar; 13(6):8095-8114. PubMed ID: 33686962
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cyclin-dependent kinases in axotomy-induced retinal ganglion cell death.
Lefèvre K; Clarke PG; Danthe EE; Castagné V
J Comp Neurol; 2002 May; 447(1):72-81. PubMed ID: 11967896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
